Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Metadata
Title
Validation Study of a Hebrew Version of WOMAC in Patients with Osteoarthritis of the Knee
Authors
I. Wigler
L. Neumann
M. Yaron
Publication date
01-09-1999
Publisher
Springer-Verlag London Limited
Published in
Clinical Rheumatology / Issue 5/1999
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s100670050126

Other articles of this Issue 5/1999

Clinical Rheumatology 5/1999 Go to the issue

Original Article

The Influence of a Joint Orthosis on the Grip Force of the Rheumatoid Hand

Original Article

Investigation of the Alveolar Macrophages and T Lymphocytes in 15 Patients with Systemic Sclerosis

Original Article

Urinary Thrombomodulin in Patients with Rheumatoid Arthritis: Relationship to Disease Subset

OriginalPaper

Spondylodiscitis Caused by Viridans Streptococci: Three Cases and a Review of the Literature

Original Article

Influence of Disease Activity and Chronicity on Ankylosing Spondylitis Bone Mass Loss

Original Article

Decreased CD4+ Lymphocyte Activation and Increased Interleukin-4 Production in Peripheral Blood of Rheumatoid Arthritis Patients After Acute Starvation

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits